Log in
NYSEAMERICAN:MTNB

Matinas BioPharma Earnings Date, Estimates & History

$0.80
+0.01 (+1.26 %)
(As of 09/18/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.78
Now: $0.80
$0.81
50-Day Range N/A
52-Week Range
$0.49
Now: $0.80
$2.49
Volume1.74 million shs
Average Volume2.42 million shs
Market Capitalization$159.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Earnings

Matinas BioPharma (NYSEAMERICAN:MTNB) Earnings Information

Matinas BioPharma last announced its quarterly earnings data on August 10th, 2020. The reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). Matinas BioPharma has generated $0.00 earnings per share over the last year. Matinas BioPharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 11th, 2020 based off prior year's report dates.

Matinas BioPharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Matinas BioPharma (NYSEAMERICAN:MTNB) Earnings Estimates

2020 EPS Consensus Estimate: ($0.14)
2021 EPS Consensus Estimate: ($0.18)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.03)($0.03)($0.03)
Q2 20201($0.03)($0.03)($0.03)
Q3 20202($0.04)($0.03)($0.04)
Q4 20201($0.04)($0.04)($0.04)
Q1 20211($0.03)($0.03)($0.03)
Q2 20211($0.05)($0.05)($0.05)
Q3 20211($0.05)($0.05)($0.05)
Q4 20211($0.05)($0.05)($0.05)

Matinas BioPharma (NYSEAMERICAN MTNB) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/11/2020
(Estimated)
       
8/10/20206/30/2020($0.03)($0.03)($0.03)Transcript
5/11/20203/31/2020($0.03)($0.03)($0.03)$0.07 millionTranscript
3/9/202012/31/2019($0.03)($0.04)($0.04)$0.07 millionTranscript
11/13/2019Q3($0.03)($0.03)($0.03)$0.04 millionTranscript
8/13/2019Q2 2019($0.04)($0.03)($0.03)$0.06 million$0.09 millionN/A
8/13/2019Q2 2019($0.04)($0.03)($0.03)$0.06 million$0.09 millionN/A
5/13/2019Q1 2019($0.03)($0.04)($0.04)N/A
5/13/2019Q1($0.03)($0.04)($0.04)$0.03 millionN/A
4/2/2019Q4 2018($0.03)($0.03)N/A
4/2/201912/31/2018($0.03)($0.03)($0.03)Transcript
11/12/2018Q3 2018($0.03)($0.03)N/A
11/12/2018Q3 2018($0.03)($0.03)N/A
8/10/2018Q2 2018($0.04)($0.04)$0.09 millionN/A
8/10/2018Q2 2018($0.04)($0.04)($0.04)$0.09 millionN/A
5/10/2018Q1 2018($0.05)($0.05)$0.03 millionN/A
5/10/2018Q1 2018($0.04)($0.05)($0.05)$0.03 millionTranscript
3/26/2018Q4 2017($0.03)($0.03)$0.05 millionN/A
3/26/2018Q4 2017($0.03)($0.03)$0.05 millionN/A
11/15/2017Q3 2017($0.05)($0.04)($0.04)$0.05 million$0.05 millionN/A
11/15/2017Q3 2017($0.05)($0.04)($0.04)$0.05 million$0.05 millionN/A
8/8/2017Q2 2017($0.05)($0.04)($0.04)$0.02 million$0.05 millionN/A
8/8/2017Q2 2017($0.05)($0.04)($0.04)$0.02 million$0.05 millionListen
5/16/2017Q1 2017($0.25)($0.25)$0.02 millionN/A
5/16/2017Q1 2017($0.0350)($0.25)($0.25)$0.02 millionN/A
4/3/2017Q4 2016($0.03)($0.03)N/A
4/3/2017Q4 2016($0.08)($0.03)($0.03)Listen
11/15/2016Q3 2016($0.11)($0.11)N/A
11/15/2016Q3 2016($0.11)($0.11)N/A
8/15/2016Q2 2016($0.03)($0.03)N/A
8/15/2016Q2 2016($0.03)($0.03)N/A
5/13/2016Q1 2016($0.04)($0.04)N/A
5/13/2016Q1 2016($0.04)($0.04)N/A
3/30/2016Q4 2015($0.03)($0.03)N/A
3/30/2016Q4 2015($0.03)($0.03)N/A
11/10/2015Q3 2015($0.05)($0.04)($0.04)$0.10 million$0.06 millionN/A
11/10/2015Q3 2016($0.03)($0.11)($0.11)$0.10 million$0.06 millionN/A
8/13/2015Q2 2015($0.05)($0.04)($0.04)$0.10 million$0.08 millionN/A
8/13/2015Q2 2015($0.05)($0.04)($0.04)$0.10 million$0.08 millionN/A
5/11/2015Q1 2015($0.08)($0.07)($0.07)$0.06 millionN/A
5/11/2015Q1 2015($0.08)($0.07)($0.07)$0.06 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.